Programmed Death Receptor-1 Blocking Antibody


Nivolumab desired effects:

  • Increased Lymphocyte Cell Production

Nivolumab drug classes:

  • Programmed Death Receptor-1 Blocking Antibody

Nivolumab pharmacologic actions:

  • Immune Checkpoint Inhibitors
  • Antineoplastic Agents, Immunological

Nivolumab mechanism of action:

  • Programmed Death Receptor-1-directed Antibody Interactions
  • treatable

The content offered on is intended for informational purposes only and not as medical advice. For medical advice you should consult an appropriately licensed and qualified medical professional. If you are experiencing acute or distressing symptoms or life threatening symptoms you should immediately call 911 and/or go to the nearest emergency medical facility.

Copyright © Treatable 2022
Last updated: 10/16/2022, 8:11:57 AM